Serum leptin as an additional possible pathogenic factor in polycystic ovary syndrome

Clinical Biochemistry

Volumn 32, Issue 1, 1999, Pages 71-75

  El Orabi, Hussein ^a   Abou Ghalia, Azza ^a   Khalifa, Aly ^a   Mahfouz, Hala ^a   El Shalkani, Amr ^a   Shoieb, Nehad ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Leptin; PCOS

Indexed keywords

LEPTIN;

ADIPOCYTE; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; DRUG BLOOD LEVEL; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR GENE; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INSULIN; LEPTIN; LUTEINIZING HORMONE; MIDDLE AGED; OBESITY; POLYCYSTIC OVARY SYNDROME; PROLACTIN; PROTEINS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 0345222476     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(98)00091-5     Document Type: Article

References (27)

1. Zhang Y., Proenca R., Maffel M., et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425.
2. Dunaif A. Hyperandrogenic anovulation (PCOS) a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus . Am J Med. 98:1995;335.
3. Dunaif A., Xia J., Book C.B., Schenker E., Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest. 96:1995;801.
4. Book C.B., Dunaif A. Insulin resistance in the polycystic ovary syndrome. Chang R.J. Polycystic ovary syndrome. Serono Symp YSA. 1996;117-125 Springer-Verlag, New York.
5. Cloffi J.A., Shafer A.W., Zupanclc T.J., et al. Novel B219.OB receptor isoforms possible role of leptin in hematopoiesis and reproduction . Nature Med. 2:1996;585.
6. Tartaglia L.A., Dembski M., Weng X., et al. Identification and expression cloning of a leptin receptor, OB-R. Cell. 83:1995;1263.
7. Brzechffa P.R., Jakimiuk J., Agarwal S.K., et al. Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 81:1996;4166.
8. Caro J.F. Leptin is normal in PCOS, an editorial about three "negative" papers. J Clin Endocrinol Metabol. 82:(6):1997;1685.
9. Laughlin G.A., Morales A.J., Yen S.C. Serum leptin levels in women with polycystic ovary syndrome the role of insulin resistance/ hyperinsulinaemia . J Clin Endocrinol Metab. 82:1997;1692.
10. Mantzoros C.S., Dunaif A., Flier J.S. Leptin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metabol. 82:1997;1687.
11. Rouru J., Anttila L., Koskela P., et al. Serum leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 82:1997;1697.
12. Hammond G.L., Langely M.S., Robinson P.A. A liquid-phase immunoradiometric assay (IRMA) for human sex hormone binding globulin (SHBG). J Steroid Biochem. 23:1985;451.
13. Carlstron K., Gerhagen S., Rannevik G. Free testosterone and testosterone/SHBG index in hirsute women a comparison of diagnostic accuracy . Gynaecol Obstet Invest. 24:1987;256.
14. Ma Z., Gingerich R.L., Santiago J.V., et al. Radioimmunoassay of leptin in human plasma. Clin Chem. 6:1996;942.
15. Barash I.A., Cheung C.C., Weigle D.S., et al. Leptin is a metabolic signal to the reproductive system. Endocrinology. 137:1996;3144.
16. Chelab F.F., Lim M.E., Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nature Genet. 12:1996;318.
17. Lee G., Proenca R., Montez J.M., et al. Abnormal splicing of the leptin receptors in diabetic mice. Nature. 379:1996;632.
18. Eden J.A., Carter G.D., Place J., et al. Elevated free androgen index is an indicator of polycystic ovaries in oligomenorrhea without obesity or hirutism. Ann Clin Biochem. 25:1988;346.
19. Goldziehere J.W. Polycystic ovarian disease. Fertil Steril. 35:1981;371.
20. Dunaif A., Segal K.R., Shelley D.R., et al. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 41:1992;1257.
21. Morales A.J., Laughlin G.A., Butzow T., et al. Insulin' somatotropic, and leuteinizing hormone axes in lean and obese women with polycystic ovary syndrome common and distinct features . J Clin Endocrinol Metab. 81:(8):1996;2854.
22. Cusin I., Sinsburg A., Doyle P., Rohner-Jeanrenaud F., Jeanrenaud B. The ob gene and insulin a relationship leading to clues to the understanding of obesity . Diabetes. 44:1995;1467.
23. Saladin R., De vos P., Guerre-Millo M., et al. Transient increase in obese gene expression after food intake or insulin administration. Nature. 377:1995;527.
24. Dagogo-Jack S., Fanelli C., Paramore D., Brothers J., Landt M. Plasma leptin and insulin relationships in obese and non obese humans. Diabetes. 45:1996;695.
25. Dunaif A., Segal K.R., Futterweit W., Dobrjansty A. Profound peripheral insulin resistance independent of obesity in polycystic ovary syndrome. Diabetes. 38:1989;1165-1174.
26. Rosenbaum D., Haber R.S., Dunaif A. Insulin resistance in polycystic ovary syndrome decreased expression of GLUT-4 glucose transports in adipocytes . Am J Physiol. 246:1993;E197.
27. Kolaczynsk J.W., Nyce M.R., Considine R.V., et al. Acute and chronic effects of insulin on leptin production in humans. Diabetes. 45:1996;699.